Drug maker recalls Naloxone due to loose matter on syringe
Jun 07 2018 by Kathy Alvarado
Naloxone is used to revive a person who is overdosing on opiates, such as heroin.
If someone is exposed to the particulate, Hospira says there is a low chance of experiencing adverse health effects, including allergic reactions and pulmonary dysfunction.
Hospira, the manufacturer of the antidote for opioid overdose Neloxone, has recalled the drug for particulate matter, said The Food and Drug Administration (FDA) on Monday. The affected products were sent to wholesalers, distributors and hospitals across the U.S., Puerto Rico and Guam between February 2017 and February 2018. However, if there is any person who experiences adverse reactions should report the matter immediately to the agency's MedWatch Adverse Event Reporting program. "Hospira, Inc., has notified wholesalers/distributors/hospitals to arrange for return of any recalled product".
Amazon to show 20 matches a season from 2019
The online streaming service has won the rights to show one round of midweek games and one round from a bank holiday. Now it has been announced that it was successful in at least part of its bid.
"DHHR's statewide distribution of naloxone to first responders is not expected to be impacted by the FDA's recall of naloxone", DHHR officials said.
When administered, Naloxone can quickly restore normal respiration to someone whose breathing has slowed or stopped due to opioids.
The voluntary recall by the Pfizer subsidiary is for Carpuject single-use cartridge syringe system (NDC 0409-1782-69) of naloxone hydrochloride injection, USP (lots 72680LL and 76510LL; 0.4 mg/mL, 1 mL in 2.5 mL doses for both lots). Nationwide, an estimated 60,000 people in the US died from drug overdoses in 2016, more than gunshots or traffic accidents.